Guide
Longevity drugs, explained simply
Some longevity-drug candidates are real, approved medicines.
Evidence:Human observational evidenceRisk:High risk
In plain English
Longevity drugs, explained simply
These are real medicines people discuss as possible longevity tools. The key question is whether human longevity benefit is proven, not whether the drug exists.
Start with these 3 questions
Is the evidence about aging itself or a disease proxy?
Is use approved, off-label or trial-only?
What outcomes matter beyond biomarkers?
What should you do with this information?
- Use it to ask better questions, not to self-experiment.
- Do not use this page for dosing, sourcing, stacking or self-administration decisions.
- Speak with a qualified clinician before acting on high-risk claims.
Start with these guides
Plain-English pages for the questions people usually ask first.
Question
What is rapamycin?
Rapamycin, also known as sirolimus, is a real medicine approved for specific uses and a serious geroscience candidate.
Evidence:Human trial evidenceRisk:High risk
Question
Why is rapamycin discussed for longevity?
Rapamycin is discussed because mTOR biology and animal lifespan findings are unusually important in aging science.
Evidence:Human trial evidenceRisk:High risk
Question
What did the PEARL rapamycin trial show?
PEARL adds useful human data on rapamycin safety and selected healthspan metrics after one year.
Evidence:Human trial evidenceRisk:High risk
Question
Rapamycin risks and side effects
Rapamycin affects immune and metabolic pathways and is a real prescription drug, not a supplement.
Evidence:Human trial evidenceRisk:High risk
Question
What is metformin?
Metformin is a widely used diabetes drug and a serious geroscience candidate. It is not proven to extend lifespan in healthy non-diabetic adults.
Evidence:Human observational evidenceRisk:Moderate risk
Question
Semaglutide vs tirzepatide vs retatrutide: the safe plain-English comparison
Semaglutide, tirzepatide and retatrutide are not interchangeable wellness tools.
Evidence:Human trial evidenceRisk:High risk
Question
Do GLP-1 drugs cause muscle loss?
GLP-1-based weight loss can include loss of lean mass, but 'lean mass' is not exactly the same as useful muscle.
Evidence:Human trial evidenceRisk:Moderate risk
Question
Protein, leucine and BCAAs on GLP-1s: what is evidence and what is gym lore?
Protein quality, resistance training and preserving function matter during weight loss.
Evidence:Human observational evidenceRisk:Lower risk
Most asked claims
Longevity drugs
Does rapamycin slow aging in humans?
Rapamycin has unusually strong aging-biology interest, but it is not proven to slow human aging or extend lifespan in healthy adults.
Evidence:Human trial evidenceRisk:High risk
Longevity drugs
Does metformin extend lifespan in healthy non-diabetic adults?
Metformin is an important diabetes drug and longevity candidate, but it is not proven to extend lifespan in healthy non-diabetic adults.
Evidence:Human observational evidenceRisk:Moderate risk
Key terms
- Geroprotector
- A proposed intervention intended to modify biological aging processes, not merely treat one disease endpoint.
- Off-label
- Use of an approved drug outside its FDA-approved indication, population or condition.
Show deeper evidenceGuides, evidence ladder, latest updates and FAQs.+
The evidence ladder
We ask a simple question first: how close is this claim to proof in real people?
- 1
Proven enough for standard use
Human evidence and accepted medical use for the specific purpose.
- 2
Promising but not settled
Some human data or strong early evidence, with important questions still open.
- 3
Mostly animal or lab evidence
Interesting science, but not proof it works in people.
- 4
Theory, hype or anecdotes
People talk about it, but reliable evidence is weak.
- 5
Regulatory or safety warning
The main story is approval status, legality, quality or risk.
More guides and updates
Mechanism
Rapamycin and mTOR, explained simply
mTOR is a nutrient-sensing pathway involved in growth, repair and metabolism.
Evidence:Early theoryRisk:High risk
Question
Why rapamycin is off-label for longevity
Rapamycin can be an approved drug and still be off-label for longevity.
Evidence:Regulatory watchRisk:High risk
Safety guide
What to ask a doctor about rapamycin
Ask what indication is being considered, what human evidence applies, what risks and monitoring matter, what alternatives exist and what would count...
Evidence:Human trial evidenceRisk:High risk
Question
Metformin risks and side effects
Metformin is familiar and widely used, but it is still a drug with contraindications, interaction and monitoring questions.
Evidence:Human observational evidenceRisk:Moderate risk
Question
Metformin vs rapamycin for longevity claims
Metformin and rapamycin are both discussed in geroscience, but they are not interchangeable.
Evidence:Human observational evidenceRisk:High risk
Guide
Does rapamycin slow aging in humans?
Rapamycin is one of the most discussed geroscience drugs, but human longevity evidence remains incomplete.
Evidence:Human trial evidence
Guide
What did the PEARL rapamycin trial actually show?
PEARL is important because it asks human questions, but readers should distinguish trial signals from sweeping longevity claims.
Evidence:Human trial evidence
Guide
Metformin for longevity: what TAME is trying to answer.
TAME is designed around whether one approved diabetes drug can affect multiple aging-related outcomes, but it is not a completed answer.
Evidence:Trial registered
Latest updates
ClinicalTrials.gov
Jun 27, 2026
Evidence:Trial registeredRisk:High riskStatus:Off-label
Rapamycin longevity claims should be mapped to registered human endpoints
Registry searches help distinguish actual human study questions from podcast-level certainty.
A registered trial is stronger than anecdote, but interpretation depends on design, outcomes and reporting.
FAQs
Do approved drugs become approved longevity drugs automatically?
No. Approval for one medical use does not establish approval for longevity or aging claims.
Get the weekly longevity evidence briefing.
One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.
No protocols. No miracle claims. No spam.